|
董 培新 (ドン バイシン）は、日本の癌研究者。北海道大学医学部助教。 == 略歴 == *1997年6月 中国ハルビン医科大学卒業 *1997年8月 中国ハルビン医科大学付属黒龍江省電力病院婦人科医員 *2002年10月 福岡大学医学部産婦人科研究員 *2004年4月 北海道大学大学院医学研究科婦人科専攻入学 *2008年3月 北海道大学大学院医学研究科婦人科専攻終了(博士号取得) *2008年4月 中国上海復旦大学付属産婦人科病院助手 *2009年4月 中国上海復旦大学付属産婦人科病院講師 *2010年4月 北海道大学医学研究科総合女性医療システム学助教 == 受賞歴 == *平成23年度 北海道産科婦人科学会賞（October 28, 2012）受賞 *平成27年度 北海道大学研究総長賞（February 3, 2016）受賞 == 所属学会 == *日本産婦人科学会（会員：平成２３年～現在） *北海道産婦人科学会（会員：平成２３年～現在） *日本RNA学会（会員：平成２６年～現在） == 社会における活動 == 国際誌Editorial Board Member： *Journal of Cancer Research & Therapy、2013年～2015年 *Cancer Growth and Metastasis、2013年～2015年 *Austin Journal of Women’s Health、2014年～現在 国際誌reviewer： *Molecular Oncology *Molecular Cancer *Journal of Translational Medicine *Gynecologic Oncology *BMC Cancer *Journal of Experimental & Clinical Cancer Research *FEBS Letters *Molecular and cellular biochemistry *International Journal of Gynecology & Obstetrics == 専攻分野 == *婦人科癌転移の分子メカニズムの解明と新しい分子標的治療法の探索 == 参考文献 == * eBook: Peixin Dong: Molecular targets and targeted therapy. pp. 182-199. (Noriaki Sakuragi eds., Current Approaches to Endometrial Cancer. Future Medicine Ltd, UK), 2014. * Peixin Dong *, Masanori Kaneuchi, Yosuke Konno, Hidemichi Watari, Satoko Sudo, Noriaki Sakuragi: Emerging therapeutic biomarkers in endometrial cancer. Biomed Res Int 2013, 130362-130373, 2013 ( *Corresponding author) * Peixin Dong *, Yosuke Konno, Hidemichi Watari, Masayoshi Hosaka, Masayuki Noguchi, Noriaki Sakuragi: The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer. J Transl Med 12, 231-240, 2014 * Peixin Dong *, Kei Ihira, Junichi Hamada, Hidemichi Watari, Takahiro Yamada, Masayoshi Hosaka, Sharon J.B. Hanle, Masataka Kudo and Noriaki Sakuragi: Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors. Oncotarget 6, 19968-19975, 2015 * Dong P, Nabeshima K *, Nishimura N, Kawakami T, Hachisuga T, Kawarabayashi T, Iwasaki H: Overexpression and diffuse expression pattern of IQGAP1 at invasion fronts are independent prognostic parameters in ovarian carcinomas. Cancer Lett 243, 120-127, 2006 (IF=4.960) * Dong P, Tada M, Hamada J, Nakamura A, Moriuchi T, Sakuragi N *: p53 dominant-negative mutation R273H promotes invasion and migration of human endometrial cancer HHUA cells. Clin Exp Metastasis 24, 471-483, 2007 (IF=3.770) * Dong P *, Jia N, Xu ZJ, Liu YT, Li DJ, Feng YJ: Silencing of IQGAP1 by shRNA inhibits the invasion of ovarian carcinoma HO-8910PM cells in vitro. J Exp Clin Cancer Res 27, 77-85, 2008 (IF=3.730) * Jia N *, Dong P, Huang Q, Jin W, Zhang J, Dai Q, Liu S: Cardioprotective effects of granulocyte colony-stimulating factor in Angiotensin-II Induced Cardiac Remodeling. Clin Exp Pharmacol Physiol 36, 262-266, 2009 (IF=2.370) * Dong P *, Xu Z, Jia N, Li D, Feng Y: Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway. Mol Cancer 8, 103-110, 2009 (IF=5.220) * Peixin Dong, Masanori Kaneuchi, Hidemichi Watari, Junichi Hamada, Satoko Sudo, Jingfang Ju, Noriaki Sakuragi *: MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer 10, 99-108, 2011 (IF=5.220) * Nan Jia *, Peixin Dong, Ying Ye, Cheng Qian, Qiuyan Dai: Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction. Cardiovasc Ther 30, 117-123, 2012 (IF=2.444) * Tatsuya Kato, Hidemichi Watari *, Daisuke Endo, Takashi Mitamura, Tetsuji Odagiri, Yousuke Konno, Masayoshi Hosaka, Noriko Kobayashi, Yukiharu Todo, Satoko Sudo, Mahito Takeda, Peixin Dong, Masanori Kaneuchi, Masataka Kudo, Noriaki Sakuragi: New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system. J Surg Oncol 106, 938-941, 2012 (IF=3.088) * P Dong *, M Karaayvaz, N Jia, M Kaneuchi, J Hamada, H Watari, S Sudo, J Ju, N Sakuragi: Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis. Oncogene 32, 3286-3295, 2013 (IF=7.632) * Haiyan Zhai, Mihriban Karaayvaz, Peixin Dong, Noriaki Sakuragi, Jingfang Ju *: Prognostic significance of miR-194 in endometrial cancer. Biomark Res 1, 12-17, 2013 (IF=0.000) * Peixin Dong *, Masanori Kaneuchi, Ying Xiong, Liping Cao, Muyan Cai, Xishi Liu, Sun-Wei Guo, Jingfang Ju, Nan Jia, Yosuke Konno, Hidemichi Watari, Masayoshi Hosaka, Satoko Sudo, Noriaki Sakuragi: Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer. Carcinogenesis 35, 760-768, 2014 (IF=5.698) * Tetsuji Odagiri, Hidemichi Watari *, Tatsuya Kato, Takashi Mitamura, Masayoshi Hosaka, Satoko Sudo, Mahito Takeda, Noriko Kobayashi, Peixin Dong, Yukiharu Todo, Masataka Kudo, Noriaki Sakuragi: Distribution of Lymph Node Metastasis Sites in Endometrial Cancer Undergoing Systematic Pelvic and Para-Aortic Lymphadenectomy: A Proposal of Optimal Lymphadenectomy for Future Clinical Trials. Ann Surg Oncol 21, 2755-2761, 2014 (IF=4.530) * Peixin Dong *, Masanori Kaneuchi, Hidemichi Watari, Satoko Sudo, Noriaki Sakuragi: MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines. Molecular Carcinog 53, 349-359, 2014 (IF=4.180) * Yosuke Konno, Peixin Dong *, Ying Xiong, Fumihiko Suzuki, Jiabin Lu, Muyan Cai, Hidemichi Watari, Takashi Mitamura, Masayoshi Hosaka, Sharon J B Hanley, Masataka Kudo, Noriaki Sakuragi: MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. Oncotarget 5, 6049-6062, 2014 (IF=6.402) * Takashi Mitamura, Hidemichi Watari *, Lei Wang, Hiromi Kanno, Masaya Miyazaki, Makiko Kitagawa, Mohamed Kamel Hassan, Peixin Dong, Taichi Kimura, Mishie Tanino, Hiroshi Nishihara, Shinya Tanaka and Noriaki Sakuragi: microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway. Mol Cancer 13, 97-108, 2014 (IF=5.220) 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「董培新」の詳細全文を読む スポンサード リンク
|